Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analyses.

Radiological imaging is essential to the appropriate management of patients with bone metastasis; however, there have been no widely accepted guidelines as to the optimal method for quantifying the potential impact of skeletal lesions or to evaluate response to treatment. The current inability to rapidly quantify the response of bone metastases excludes patients with cancer and bone disease from participating in clinical trials of many new treatments as these studies frequently require patients with so-called measurable disease. Computed tomography (CT) can provide excellent skeletal detail with a sensitivity for the diagnosis of bone metastases. The purpose of this study was to establish an objective method to quantitatively characterize disease in the bony spine using CT-based segmentations. It was hypothesized that histogram analysis of CT vertebral density distributions would enable standardized segmentation of tumor tissue and consequently allow quantification of disease in the metastatic spine. Thirty two healthy vertebral CT scans were first studied to establish a baseline characterization. The histograms of the trabecular centrums were found to be Gaussian distributions (average root-mean-square difference=30 voxel counts), as expected for a uniform material. Intrapatient vertebral level similarity was also observed as the means were not significantly different (p > 0.8). Thus, a patient-specific healthy vertebral body histogram is able to characterize healthy trabecular bone throughout that individual's thoracolumbar spine. Eleven metastatically involved vertebrae were analyzed to determine the characteristics of the lytic and blastic bone voxels relative to the healthy bone. Lytic and blastic tumors were segmented as connected areas with voxel intensities between specified thresholds. The tested thresholds were mu-1.0 sigma, mu - 1.5 sigma, and mu - 2.0 sigma, for lytic and mu + 2.0 sigma, mu+3.0 siema, and mu + 3.5 sigma for blastic tissue where mu and sigma were taken from the Gaussian characterization of a healthy level within the same patient. The ideal lytic and blastic segmentation thresholds were determined to be mu-sigma and mu + 2 sigma, respectively. Using the optimized thresholds to segment tumor tissue, a quantitative characterization of disease is possible to calculate tumor volumes, disease severity, and temporal progression or treatment effect. Our proposed histogram-based method for characterizing spinal metastases shows great potential in extending the quantitative capacity of CT-based radiographic evaluations.

[1]  R. Rubens,et al.  Bone metastases--the clinical problem. , 1998, European journal of cancer.

[2]  G D Roodman,et al.  Biology of osteoclast activation in cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Cs,et al.  Skeletal metastases and mammary cancer. , 1972 .

[4]  G. Hortobagyi,et al.  Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  DAVID A. WONG,et al.  Spinal Metastases: The Obvious, the Occult, and the Impostors , 1990, Spine.

[6]  J. Rubenstein,et al.  Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy--a feasibility study. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  G. Hortobagyi,et al.  Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy , 1984, Cancer.

[8]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer (an amendment) , 1978, British Journal of Cancer.

[9]  Yeu‐Tsu N. Lee,et al.  Bone scanning in patients with early breast carcinoma: Should it be a routine staging procedure? , 1981, Cancer.

[10]  Naoto T Ueno,et al.  Bone imaging in metastatic breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Coleman Monitoring of bone metastases. , 1998, European journal of cancer.

[12]  D. Dershaw,et al.  Imaging techniques in breast cancer. , 1989, Seminars in surgical oncology.

[13]  R E O'Mara,et al.  Skeletal scanning in neoplastic disease , 1976, Cancer.

[14]  W. Greig,et al.  A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. , 1977, Clinical radiology.

[15]  M. Sundaram,et al.  Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor-like lesion of bone? , 2004, Skeletal Radiology.

[16]  F. Doyle,et al.  The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. , 1972, Clinical radiology.

[17]  I. Fogelman,et al.  The role of positron emission tomography in the management of bone metastases , 2000, Cancer.

[18]  R. Coleman,et al.  The management of bone metastases. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  J H Thrall,et al.  Solitary abnormalities in bone scans of patients with extraosseous malignancies. , 1976, Radiology.

[20]  R. Rubens,et al.  Reappraisal of the baseline bone scan in breast cancer. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  N. Janjan Bone metastases: approaches to management. , 2001, Seminars in oncology.

[22]  T. Powles,et al.  The role of computed tomography in the detection of bone metastases in breast cancer patients. , 1983, The British journal of radiology.

[23]  G. Hortobagyi,et al.  Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Rubens,et al.  The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.

[25]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.

[26]  D. Kido,et al.  Comparative sensitivity of CT scans, radiographs and radionuclide bone scans in detecting metastatic calvarial lesions. , 1978, Radiology.

[27]  R. Daffner,et al.  MRI in the detection of malignant infiltration of bone marrow. , 1986, AJR. American journal of roentgenology.

[28]  C. Whyne,et al.  Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method. , 2007, Medical physics.

[29]  B. A. Goddard,et al.  Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging. , 1981, The British journal of radiology.

[30]  M. Tubiana-Hulin,et al.  Incidence, prevalence and distribution of bone metastases. , 1991, Bone.

[31]  Bonnie N Joe,et al.  Adrenal masses: CT characterization with histogram analysis method. , 2003, Radiology.

[32]  Takashi Ohtsuka,et al.  Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness. , 2003, The Journal of thoracic and cardiovascular surgery.

[33]  T. Sanders,et al.  Radiographic imaging of musculoskeletal neoplasia. , 2001, Cancer control : journal of the Moffitt Cancer Center.

[34]  C. Galasko The value of scintigraphy in malignant disease. , 1975, Cancer treatment reviews.

[35]  R. Eastell,et al.  Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. , 1996, Cancer treatment reviews.

[36]  L. Rybak,et al.  Radiological imaging for the diagnosis of bone metastases. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[37]  G. Edelstyn,et al.  The radiological demonstration of osseous metastases. Experimental observations. , 1967, Clinical radiology.

[38]  P. LoRusso Analysis of skeletal-related events in breast cancer and response to therapy. , 2001, Seminars in oncology.

[39]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.